An umbrella review and meta‐analysis of renin–angiotensin system drugs use and COVID‐19 outcomes

A Kurdi, T Mueller, N Weir - European journal of clinical …, 2023 - Wiley Online Library
Background Despite the availability of extensive literature on the effect of angiotensin‐
converting enzyme inhibitors (ACEIs)/angiotensin‐receptor blockers (ARBs) on COVID‐19 …

COVID-19 and the Use of Angiotensin II Receptor Blockers in Older Chronic Hypertensive Patients: Systematic Review and Meta-Analysis

M Quesada-Caballero, A Carmona-Garcia… - Medicina, 2023 - mdpi.com
Angiotensin II-converting enzyme inhibitors (ACEIs) and selective angiotensin II receptor
antagonists (ARAIIs) are widely used antihypertensive agents. Their use has generated …

Serial echocardiographic evaluation of COVID-19 patients without prior history of structural heart disease: a 1-year follow-up CRACoV-HHS study

A Olszanecka, W Wojciechowska… - Frontiers in …, 2023 - frontiersin.org
Background It is a well-known fact that COVID-19 affects the cardiovascular system by
exacerbating heart failure in patients with preexisting conditions. However, there is a poor …

Home Oxygen After Hospitalization for COVID-19: Results From the Multi-Center OXFORD Study

MB Freedman, YJ Kim, R Kaur, BV Jain… - Respiratory …, 2024 - rc.rcjournal.com
BACKGROUND: In the first months of the pandemic, prior to the introduction of proven-
effective treatments, 15–37% of patients hospitalized with COVID-19 were discharged on …

Emerging topics on basic research in hypertension: interorgan communication and the need for interresearcher collaboration

K Shinohara - Hypertension Research, 2023 - nature.com
The pathogenesis of hypertension is multifactorial and highly complex. Basic research plays
critical roles in elucidating the complex pathogenesis of hypertension and developing its …

From cardiovascular system to brain, the potential protective role of mas receptors in COVID-19 infection.

P Cappelletti, G Gallo, R Marino, S Palaniappan… - European Journal of …, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has been declared a new pandemic in
March 2020. Although most patients are asymptomatic, those with underlying cardiovascular …

Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study

K Zhang, H Gao, M Chen - Frontiers in Pharmacology, 2023 - frontiersin.org
Background: Observational investigations have provided conflicting results regarding the
effect of antihypertensive drugs on the risk of COVID-19 outcomes. We intended to assess …

The necessity of investigations to clarify sex and racial disparities in pathophysiology of Long COVID

C Matsumoto - Hypertension Research, 2024 - nature.com
As of November 2023, people's daily lives are returning to pre-COVID-19 conditions without
the behavioral restrictions that were imposed at the beginning of the COVID-19 pandemic …

Caractéristiques cliniques, biologiques, radiologiques et thérapeutiques de la COVID-19 en Afrique subsaharienne

DN Ndabahweje, CK Kahindo, ML Tshikwela… - Journal of Medicine …, 2024 - pugoma.com
Résumé Cet article de revue de littérature offre une analyse approfondie des
caractéristiques cliniques, biologiques, radiologiques et thérapeutiques de la COVID-19 en …

[PDF][PDF] Orapuh Journal

CA Motuta, LL Koko, E Biembe, MK Lutete, M Mawunu… - 2024 - researchgate.net
Orapuh Journal Page 1 Orapuh Journal 1 OPEN ACCESS Orapuh | orapj.orapuh.org https://dx.doi.org/10.4314/orapj.v5i1.8
ORIGINAL ARTICLE Journal of Oral & Public Health Epidemiological, clinical, and …